Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

TLR9 inhibitor-loaded nanoparticles protect against radiation-induced BBB disruption

April 12, 2022

Targeting 5-HT1AR as novel therapeutic strategy for Fragile X syndrome

April 12, 2022

Janssen describes new Casein kinase I isoform delta inhibitors

April 12, 2022

GPR171 agonism ameliorates chronic neuropathic and inflammatory pain

April 8, 2022

1st Bio Therapeutics presents new protein kinase inhibitors

April 8, 2022

Alternate approach could enable earlier detection, intervention, in Alzheimer's

April 7, 2022

BETR-001 shows antidepressant activity in preclinical models

April 7, 2022

Novel series of glucosylceramide synthase inhibitors presented for treating Parkinson's disease

April 7, 2022

Compass Pathfinder synthesizes new safrylamine derivatives

April 5, 2022

HCAR2 targeting modulates the progression of AD in mice

April 5, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
Other news to note for July 20, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cellution, Dimerix, Elutia, IPG, Jasper, Kira, Lumibird, Medtronic,...